Latest News

Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both...

With its stock down 14% over the past three months, it is easy to disregard Aurionpro Solutions (NSE:AURIONPRO...

It's not a stretch to say that Marksans Pharma Limited's ( NSE:MARKSANS ) price-to-earnings (or "P/E") ratio of 22.2x...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Significant insider control over Uno Minda implies vested interests in company growth The top 2...

Mangalam Organics Limited's ( NSE:MANORG ) price-to-earnings (or "P/E") ratio of 16.6x might make it look like a buy...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

It hasn't been the best quarter for Themis Medicare Limited ( NSE:THEMISMED ) shareholders, since the share price has...

Bajaj Electricals Limited's ( NSE:BAJAJELEC ) price-to-earnings (or "P/E") ratio of 48.7x might make it look like a...

Leoch International Technology Limited ( HKG:842 ) shareholders that were waiting for something to happen have been...

Balkrishna Industries' (NSE:BALKRISIND) stock up by 6.7% over the past three months. Given that stock prices are...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Vodafone Idea fair value estimate is ₹21.87 Current share...

There wouldn't be many who think Birlasoft Limited's ( NSE:BSOFT ) price-to-earnings (or "P/E") ratio of 25.3x is worth...

With a median price-to-earnings (or "P/E") ratio of close to 25x in India, you could be forgiven for feeling...

To the annoyance of some shareholders, Osia Hyper Retail Limited ( NSE:OSIAHYPER ) shares are down a considerable 26...

While Sudarshan Chemical Industries Limited ( NSE:SUDARSCHEM ) shareholders are probably generally happy, the stock...

Torrent Pharmaceuticals (NSE:TORNTPHARM) has had a great run on the share market with its stock up by a significant 13...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bermaz Auto Berhad fair value estimate is RM0.83 Current share...

MERCURY (TSE:5025) has had a great run on the share market with its stock up by a significant 16% over the last month...

Key Insights The considerable ownership by private companies in Beijing Energy International Holding indicates that...

SHO-BOND Holdings Co.,Ltd.'s ( TSE:1414 ) price-to-earnings (or "P/E") ratio of 19x might make it look like a sell...

Key Insights Sapporo Holdings' significant retail investors ownership suggests that the key decisions are influenced by...

Fresenius SE KGaA (XTRA:FRE) is drawing fresh attention after Fresenius Kabi agreed an exclusive cell selection technology license with TQ Therapeutics, targeting wider access to cell and gene therapies and potential expansion of its treatment toolkit. See our latest analysis for Fresenius SE KGaA. The collaboration around cell and gene therapies comes as Fresenius SE KGaA’s €51.98 share price sits on a 10.10% 3 month share price return and a 50.36% 1 year total shareholder return. This...